Two rhenium compounds with benzimidazole ligands: synthesis and DNA interactions-Reference-Cited by-同舟云学术

Two rhenium compounds with benzimidazole ligands: synthesis and DNA interactions

Published:2024 Issue:28 Volume:14 Page:19787-19793
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Shtemenko Nataliia¹²³^ORCID,Galiana-Rosello Cristina¹^ORCID,Gil-Martínez Ariadna¹^ORCID,Blasco Salvador¹^ORCID,Gonzalez-García Jorge¹^ORCID,Velichko Helen³^ORCID,Holichenko Oleksandr³^ORCID,Shtemenko Olexandr¹³^ORCID,García-España Enrique¹^ORCID

Affiliation:

1. Departamento de Química Inorgánica, Instituto de Ciencia Molecular (ICMOL), Universitat de València, C/Catedrático José Beltrán 2, 46980 Paterna, Spain

2. Oles Honchar National University, Haharina Ave, 72, Dnipro, 49000, Ukraine

3. Ukrainian State University of Chemical Technology, Haharina Ave, 8, Dnipro, 49005, Ukraine

Abstract

Two rhenium compounds with benzimidazole showed strong emission, selectively stabilized G4-quadruplexes, accumulated in cancer cells and influenced on their morphology. In silico approach was used to show the possible binding activity.

Funder

Ministerio de Ciencia e Innovación

Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valencianaa

Federación Española de Enfermedades Raras

European Cooperation in Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/RA/D4RA02669A

Reference43 articles.

1. Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era

2. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship

3. The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs

4. Benzimidazole Ring System as a Privileged Template for Anticancer Agents

5. First-row transition metal compounds containing benzimidazole ligands: An overview of their anticancer and antitumor activity